resistance

Open Access
TMPRSS2:ERG Gene Fusion Might Predict Resistance to PARP Inhibitors in Metastatic Castration-resistant Prostate Cancer
TIM SVENSTRUP POULSEN, ANDERS NYGAARD LØRUP, PER KONGSTED, RIKKE LØVENDAHL EEFSEN, MARTIN HØJGAARD and ESTRID VILMA HØGDALL

Anticancer Research October 2024, 44 (10) 4203-4211; DOI: https://doi.org/10.21873/anticanres.17250
Open Access
Loss of Malignancy of Super-Methotrexate-resistant Osteosarcoma Cells Is Associated With an Increase of Methylated Histone Marks H3K9me3 and H3K27me3
YUSUKE AOKI, YUTARO KUBOTA, NORIYUKI MASAKI, KOYA OBARA, YASUNORI TOME, MICHAEL BOUVET, KOTARO NISHIDA and ROBERT M. HOFFMAN

Anticancer Research October 2024, 44 (10) 4213-4218; DOI: https://doi.org/10.21873/anticanres.17251
Open Access
Reduced Malignancy of Super Methotrexate-resistant Osteosarcoma Cells With Dihydrofolate Reductase Amplification Despite Paradoxical Gain of Oncogenic PI3K/AKT/mTOR and c-MYC expression
YUSUKE AOKI, YUTARO KUBOTA, NORIYUKI MASAKI, KOYA OBARA, YASUNORI TOME, MICHAEL BOUVET, KOTARO NISHIDA and ROBERT M. HOFFMAN

Anticancer Research July 2024, 44 (7) 2787-2792; DOI: https://doi.org/10.21873/anticanres.17090
You have access
Disclosing Potential Therapeutic Targets Associated With Osimertinib Resistance in the Non-small Cell Lung Cancer Cell Line H1975
XUEXIA TONG, RUI ZHANG, RONG SUN, WEIZHI YANG, JINHAN SUN, JUAN CHEN and FANG LI

Anticancer Research December 2023, 43 (12) 5459-5474; DOI: https://doi.org/10.21873/anticanres.16749
You have access
Oral-recombinant Methioninase Converts an Osteosarcoma from Methotrexate-resistant to -sensitive in a Patient-derived Orthotopic-xenograft (PDOX) Mouse Model
YUSUKE AOKI, YASUNORI TOME, QINGHONG HAN, JUN YAMAMOTO, KAZUYUKI HAMADA, NORIYUKI MASAKI, YUTARO KUBOTA, MICHAEL BOUVET, KOTARO NISHIDA and ROBERT M. HOFFMAN

Anticancer Research February 2022, 42 (2) 731-737; DOI: https://doi.org/10.21873/anticanres.15531
Open Access
Induction of Cross-resistance to ABCB1 Substrates in Venetoclax-resistant Human Leukemia HL60 Cells
YUKO NAKAYAMA, KOHJI TAKARA, TETSUYA MINEGAKI, KAZUHIRO YAMAMOTO, TOMOHIRO OMURA and IKUKO YANO

Anticancer Research September 2021, 41 (9) 4239-4248; DOI: https://doi.org/10.21873/anticanres.15228
You have access
Acquisition of Letrozole Resistance Through Activation of the p38/MAPK Signaling Cascade
RASHIDRA R. WALKER, KAREN M. GALLEGOS, MELYSSA R. BRATTON, KITANI P. LEMIEUX, KUN ZHANG, GUANGDI WANG, A. MICHAEL DAVIDSON and SYREETA L. TILGHMAN

Anticancer Research February 2021, 41 (2) 583-599; DOI: https://doi.org/10.21873/anticanres.14810
You have access
Extracellular Acidity-mediated Expression of cPLA2γ Confers Resistance in Gastric Cancer Cells
SUNG-CHUL LIM, TAE-BUM LEE, BYUNG-SOO KANG and SONG IY HAN

Anticancer Research January 2021, 41 (1) 211-218; DOI: https://doi.org/10.21873/anticanres.14767
You have access
ABL1-Directed Inhibitors for CML: Efficacy, Resistance and Future Perspectives
MICHELE MASSIMINO, STEFANIA STELLA, ELENA TIRRÒ, MARIA STELLA PENNISI, SILVIA RITA VITALE, ADRIANA PUMA, CHIARA ROMANO, SANDRA DI GREGORIO, CRISTINA TOMARCHIO, FRANCESCO DI RAIMONDO and LIVIA MANZELLA

Anticancer Research May 2020, 40 (5) 2457-2465; DOI: https://doi.org/10.21873/anticanres.14215
You have access
A Triple-negative Matrix-producing Breast Carcinoma Patient-derived Orthotopic Xenograft (PDOX) Mouse Model Is Sensitive to Bevacizumab and Vinorelbine, Regressed by Eribulin and Resistant to Olaparib
JUN YAMAMOTO, TAKUYA MURATA, YOSHIHIKO TASHIRO, TAKASHI HIGUCHI, NORIHIKO SUGISAWA, HIROTO NISHINO, SACHIKO INUBUSHI, YU SUN, HYEIN LIM, KENTARO MIYAKE, ATSUSHI HONGO, TSUNEHISA NOMURA, WATARU SAITOH, TAKUYA MORIYA, HIROKAZU TANINO, CHIHIRO HOZUMI, MICHAEL BOUVET, SHREE RAM SINGH, ITARU ENDO and ROBERT M. HOFFMAN

Anticancer Research May 2020, 40 (5) 2509-2514; DOI: https://doi.org/10.21873/anticanres.14221

Main menu

User menu

Search

resistance

Pages